Vancomycin Uses, Dosage, Side Effects and Interactions
Firvanq
Firvanq is a brand of vancomycin that comes as an oral solution. An FDA-approved generic with the same active ingredient is listed.
Vancocin
Vancocin is a brand of vancomycin that comes as a capsule. An FDA-approved generic with the same active ingredient is listed.
Tyzavan
Tyzavan was approved by the FDA in February 2019 as an injection. The FDA rates no generic as a substitute for it.
Vancomycin is a glycopeptide antibiotic given by IV for serious bloodstream, heart valve, skin, bone and lung infections, and taken by mouth for C. difficile diarrhea and staphylococcal enterocolitis.
Quick links
Ask Anything About VancomycinType a question in your own words. Answered from its FDA label in seconds.Every other section of this page is in the dots on the left edge of your screen: point at one to see where it goes.Every other section of this page is one tap away: use the arrow tab on the left edge of your screen.
Vancomycin in Short
- Drug class Glycopeptide Antibacterial How the FDA classifies it
What it treatsVancomycin is an antibiotic for certain bacterial infections. Given through a vein (IV), it treats septicemia (bloodstream infection), infective endocarditis (infection of the heart valves), skin and skin structure infections, bone infections, and lower respiratory tract infections.
- How you get it Prescription only
- Comes asInjection, oral solution and capsuleAvailable strengths
Injection (by mouth, in the eye, into a vein)
- 500 mg
- 500 mg/5 mL
- 500 mg/10 mL
- 500 mg/100 mL
- 750 mg
- 750 mg/15 mL
See forms and strengths+ 26 more strengthsShow fewer strengths
Injection (by mouth, in the eye, into a vein)
- 750 mg/20 mL
- 750 mg/150 mL
- 1 g
- 1 g/20 mL
- 1 g/200 mL
- 1.25 g
- 1.25 g/25 mL
- 1.25 g/30 mL
- 1.25 g/250 mL
- 1.5 g
- 1.5 g/30 mL
- 1.5 g/300 mL
- 1.75 g/35 mL
- 1.75 g/350 mL
- 2 g/40 mL
- 2 g/400 mL
- 5 g
- 5 g/100 mL
- 10 g
- 10 g/95 mL
- 10 g/100 mL
- 100 g
Oral solution (by mouth)
- 25 mg/mL
- 250 mg/5 mL
Capsule (by mouth)
- 125 mg
- 250 mg
- The FDA’s strongest warningBoxed warning The FDA’s most serious alert. Read what it says
- Supplements and herbs50 interact 3 major, 36 moderate and 11 minor
- What pharmacies pay
- Generic$2.31 each (injections)
- Oral solution, generic: $0.40 to $2.91 per mL
The pharmacy’s own cost, national average. Not your price See every price+ 1 more price detailShow fewer price details
- Capsules, generic: $1.11 to $2.01 each
- Generic versionYes, FDA-approved Listed with the FDA, which does not mean every pharmacy stocks it
- Generic launchNovember 2035 Our estimate for the first generic of Tyzavan
The Pharmacist’s Take
Vancomycin is an antibiotic that kills bacteria mainly by blocking cell wall building, a mainstay by IV for serious bloodstream, heart valve, skin, bone and lung infections and a first choice by mouth for C. difficile diarrhea (it also treats staph infections of the bowel), on the market since about 1958 with approved generics. Oral doses are usually well tolerated beyond nausea, belly pain or diarrhea, and an IV run too fast can cause flushing and itching of the upper body. Watch for kidney and hearing damage; the boxed warning says injections containing PEG 400 and NADA (such as Tyzavan) should be avoided in the first or second trimester of pregnancy.
Key Takeaways From the HelloPharmacist Team
- Expect each IV dose to drip over at least an hour, several times a day, and oral doses 3 or 4 times daily.
- Expect blood levels and kidney tests during IV treatment, and report ringing in the ears, hearing loss, dizziness or reduced urination right away.
- Use each form only for its own job, since oral vancomycin treats only bowel infections and IV vancomycin does not treat C. difficile diarrhea.
- Report diarrhea that starts or returns during treatment or even weeks later, since C. difficile can appear or come back after antibiotics.
FDA Boxed WarningThe FDA’s strongest safety alert. Read what it says about Vancomycin.
Tyzavan and certain other vancomycin injection formulations containing PEG 400 and NADA should not be used in the first or second trimester of pregnancy if another vancomycin formulation is available. These added ingredients caused fetal malformations in animal studies. If you are pregnant or could become pregnant, tell your doctor before treatment.
Patient Information Guide for Vancomycin
What It’s Used For
Vancomycin treats several bacterial infections, depending on the product and route.
- IV vancomycin: septicemia, infective endocarditis, skin and skin structure infections, bone infections, and lower respiratory tract infections.
- Older injection labels: serious infections from methicillin-resistant staphylococci, including in penicillin-allergic patients.
- Oral vancomycin (capsules such as Vancocin, and oral solution): C. difficile-associated diarrhea and staphylococcal enterocolitis.
- Some injection products can also be given by mouth for these bowel infections.
- Oral vancomycin does not treat other infections, and IV vancomycin does not treat C. difficile diarrhea or staphylococcal enterocolitis.
How It Works
Vancomycin kills bacteria mainly by stopping them from building their cell walls. It also changes how their cell membranes let substances through and affects RNA production. It does not work against gram-negative bacilli, mycobacteria, or fungi.
The label notes no cross-resistance between vancomycin and other antibiotics.
Drug Class
Drug Class
- Glycopeptide Antibacterial
Detailed classifications and sources
The FDA sorts a drug’s active ingredient by how it works, what it does in the body and its chemical structure, and gives it one main drug class.
Drug Class
Established Pharmacologic Class (EPC)- Glycopeptide Antibacterial
The main drug class the FDA gives it. It is the class named on the drug’s label.
How It Works
Mechanism of action (MoA)None listed for Vancomycin in the FDA’s index.
What it does at the smallest level, such as a receptor or enzyme it blocks or switches on.
What It Does in the Body
Physiologic effect (PE)None listed for Vancomycin in the FDA’s index.
From our Patient Information GuideVancomycin kills bacteria mainly by stopping them from building their cell walls. It also changes how their cell membranes let substances through and affects RNA production. Read How Vancomycin Works
A change it makes in how the body works.
Chemical Family
Chemical structure (CS)- Glycopeptides
The chemical family it belongs to, by its structure.
Drug Family
WHO ATC classification- Antibiotics
- Glycopeptide antibacterials
How the World Health Organization groups it: by the part of the body it acts on and what it treats.
The classes are the FDA’s own words, from its index of drug labels, published in the National Library of Medicine’s RxClass. The description under What It Does in the Body is written by the HelloPharmacist team, not the FDA. Read the FDA’s definitions. The drug family is the World Health Organization’s ATC classification. Reference only, not medical advice.
Dosage
Vancomycin is given in different ways depending on the infection.
- IV: a slow infusion over at least 60 minutes, spread over the day, with dosing adjusted for kidney function and age.
- By mouth (capsule or oral solution): usually 3 or 4 divided doses a day for about 7 to 10 days.
- Oral solution is mixed with water first and can be kept refrigerated for two weeks.
Follow your prescriber's directions and ask your pharmacist what to do about a missed dose.
Typical Doses
Your prescriber chooses your dose, so take it exactly as prescribed.
Vancomycin Injection
Serious bacterial infections treated through a vein
People whose kidneys do not work Starting dose 15 mg/kg once
- Dose to maintain stable concentrations is 1.9 mg/kg/24 h
Good to know
Table not valid for these patients
Babies younger than 1 month · Tyzavan 15 mg/kg Starting dose 15 mg/kg once Usual dose 10 mg/kg every 12 hours in week 1 of life, then every 8 hours
- Initial dose of 15 mg/kg, followed by 10 mg/kg every 12 hours in the 1st week of life and every 8 hours thereafter up to 1 month
- Each dose over 60 minutes
Good to know
Longer intervals may be needed in premature infants
Tyzavan is a brand name for this medicine. See Tyzavan’s full dosing instructions on DailyMed →
Children Usual dose 10 mg/kg every 6 hours
- Each dose over at least 60 minutes
Good to know
Close monitoring of serum concentrations may be warranted
Children 1 month and older · Tyzavan 10 mg/kg Usual dose 10 mg/kg every 6 hours
- 10 mg/kg per dose given every 6 hours, each dose over at least 60 minutes
Tyzavan is a brand name for this medicine. See Tyzavan’s full dosing instructions on DailyMed →
Newborns up to 1 month old Starting dose 15 mg/kg once Usual dose 10 mg/kg every 12 hours in week 1 of life, then every 8 hours
- Initial dose of 15 mg/kg, followed by 10 mg/kg every 12 hours in the 1st week of life and every 8 hours thereafter up to 1 month
- Each dose over 60 minutes
Good to know
Longer intervals may be needed in premature infants
Adults with normal kidney function Usual dose 500 mg every 6 hours or 1 g every 12 hours
- The usual daily intravenous dose is 2 g divided either as 500 mg every 6 hours or 1 g every 12 hours
- Each dose at no more than 10 mg/min or over at least 60 minutes, whichever is longer
Good to know
Age or obesity may call for modification
Adults with kidney problems, creatinine clearance 100 mL/min 1,545 mg/24 h
Good to know
Initial dose no less than 15 mg/kg
Adults with kidney problems, creatinine clearance 90 mL/min 1,390 mg/24 h
Good to know
Initial dose no less than 15 mg/kg
Adults with kidney problems, creatinine clearance 80 mL/min 1,235 mg/24 h
Good to know
Initial dose no less than 15 mg/kg
Adults with kidney problems, creatinine clearance 70 mL/min 1,080 mg/24 h
Good to know
Initial dose no less than 15 mg/kg
Adults with kidney problems, creatinine clearance 60 mL/min 925 mg/24 h
Good to know
Initial dose no less than 15 mg/kg
Adults with kidney problems, creatinine clearance 50 mL/min 770 mg/24 h
Good to know
Initial dose no less than 15 mg/kg
Adults with kidney problems, creatinine clearance 40 mL/min 620 mg/24 h
Good to know
Initial dose no less than 15 mg/kg
Adults with kidney problems, creatinine clearance 30 mL/min 465 mg/24 h
Good to know
Initial dose no less than 15 mg/kg
Adults with kidney problems, creatinine clearance 20 mL/min 310 mg/24 h
Good to know
Initial dose no less than 15 mg/kg
Adults with kidney problems, creatinine clearance 10 mL/min 155 mg/24 h
Good to know
Initial dose no less than 15 mg/kg
Adults with normal kidney function · Tyzavan 2 g Usual dose 500 mg every 6 hours or 1 g every 12 hours
- 2 g divided either as 500 mg every 6 hours or 1 g every 12 hours, each dose over 60 minutes or greater
Good to know
Initial daily dose no less than 15 mg/kg
Tyzavan is a brand name for this medicine. See Tyzavan’s full dosing instructions on DailyMed →
Vancomycin Capsules
C. difficile bowel infection
For adults 18 and older
Usual dose 125 mg 4 times a day
- 125 mg orally 4 times daily for 10 days
Staph infection of the intestines
For adults 18 and older
Dose 500 mg to 2 g in 3 or 4 divided doses
- 500 mg to 2 g orally in 3 or 4 divided doses for 7 to 10 days
These are the doses for children. For adults, see “C. difficile bowel infection.”
C. difficile bowel infection and staph infection of the intestines
For children under 18
Highest dose 2 g a day
- 40 mg/kg in 3 or 4 divided doses for 7 to 10 days
Vancomycin Oral Solution
C. difficile bowel infection and staph infection of the intestines
Adults Dose 500 mg to 2 g in 3 or 4 divided doses
- Total daily dosage 500 mg to 2 g orally in 3 or 4 divided doses for 7 to 10 days
Children Highest dose 2 g a day
- 40 mg/kg in 3 or 4 divided doses for 7 to 10 days
Side Effects
Side effects differ by route. The most common with oral vancomycin were:
Common side effects
- Nausea
- Abdominal pain
- Low potassium (hypokalemia)
- Vomiting
- Diarrhea
- Gas (flatulence)
- Fever
- Headache
When to get medical help
- Call your doctor if you notice ringing in the ears, hearing loss, dizziness or vertigo.
- Get help for decreased urination, swelling or other signs of kidney problems.
- Seek urgent help for a rash, mouth sores, or blisters. Vancomycin may need to be stopped.
- Get help right away for wheezing, trouble breathing, hives, chest pain, or flushing and itching of the face, neck and upper body during an infusion.
- Tell your doctor about diarrhea that starts during or even weeks after antibiotic treatment.
- Report pain, redness or swelling at the IV site.
Seek help quickly for hearing changes, kidney problems, severe skin reactions, or breathing trouble and flushing during an infusion.
Warnings and Precautions
- Kidney injury can occur, with higher risk in older adults, those with kidney disease, and people taking other kidney-harming drugs.
- Hearing damage, including ringing in the ears and dizziness, can be temporary or permanent.
- Severe skin reactions can occur. Seek help at the first sign of a rash, mouth sores or blisters.
- Low white blood cell counts have been reported, so blood counts may be checked.
- Fast IV infusion can cause low blood pressure and flushing.
- C. difficile diarrhea can occur after antibiotics.
- Vancomycin may be absorbed in the body in some people taking it by mouth, especially with inflamed bowel.
- Tyzavan carries a boxed warning about pregnancy.
Interactions
Some drugs raise the risk of vancomycin side effects.
- Piperacillin/tazobactam: higher chance of acute kidney injury.
- Other kidney- or ear-harming drugs, such as aminoglycosides: need closer monitoring.
- Anesthetic agents: can cause redness and flushing.
Interactions Listed in the FDA-Approved Label
From the Vancomycin prescribing information (“Drug Interactions”): what the manufacturer studied or reported to the FDA.
-
Anesthetic agentsWhat happensConcomitant use has been associated with erythema and histamine-like flushing.What to doAdminister vancomycin prior to intravenous anesthetic agents to reduce risk of infusion related reactions.
-
Piperacillin/tazobactamWhat happensIncreased incidence of acute kidney injury compared to vancomycin alone; no pharmacokinetic interactions noted.What to doMonitor kidney function.
-
Ototoxic and/or nephrotoxic drugsWhat happensConcurrent and/or sequential systemic or topical use of other potentially neurotoxic and/or nephrotoxic drugs requires more frequent monitoring of renal function.What to doMore frequent monitoring of renal function.
Read the label’s full interactions text
7 DRUG INTERACTIONS Concomitant administration of vancomycin and anesthetic agents has been associated with erythema and histamine-like flushing. Anesthetic Agents: Concomitant administration of vancomycin and anesthetic agents has been associated with erythema and histamine-like flushing. Piperacillin/Tazobactam: Increased incidence of acute kidney injury in patients receiving concomitant piperacillin/tazobactam and vancomycin as compared to vancomycin alone. Monitor kidney function in patients 7.1 Anesthetic Agents Concomitant administration of vancomycin and anesthetic agents has been associated with erythema and histamine-like flushing. 7.2 Piperacillin-Tazobactam Studies have detected an increased incidence of acute kidney injury in patients administered concomitant piperacillin/tazobactam and vancomycin as compared to vancomycin alone. Monitor kidney function in patients receiving concomitant piperacillin/tazobactam and vancomycin. No pharmacokinetic interactions have been noted between piperacillin/tazobactam and vancomycin. 7.3 Ototoxic and/or Nephrotoxic Drugs Concurrent and/or sequential systemic or topical use of other potentially, neurotoxic and/or nephrotoxic drugs requires more frequent monitoring of renal function.
Not a complete list. The label covers the interactions the manufacturer studied or reported, and our own interaction database does not cover every medicine either. Bring your full medication list, including vitamins and herbal products, to your pharmacist.
Before You Start
- Do not use if you are allergic to vancomycin.
- Tell your doctor about a corn allergy, since dextrose solutions may not be suitable.
- Tell your doctor about kidney problems or hearing loss.
- Older adults need kidney monitoring and careful dosing.
- Children may have more severe infusion reactions.
- Tyzavan is not recommended in the first or second trimester of pregnancy.
- There is not enough data on vancomycin in breast milk, so discuss breastfeeding with your doctor.
Overdose
The label advises supportive care, including maintaining kidney filtration. Vancomycin is poorly removed by standard dialysis. Contact a Poison Control Center for current treatment information.
Half-Life and How Your Body Processes It
Vancomycin is poorly absorbed from the gut, so oral doses act mainly in the bowel. Given IV, it spreads into body fluids and tissues, is about 55% protein bound, and is not metabolized. About 75% is cleared in urine in the first 24 hours. Half-life is 4 to 6 hours with normal kidneys, and about 7.5 days with no kidney function. Clearance may be lower in older adults.
Storage
Store below 25°C (77ºF), in original package.
Written from the FDA-approved label with AI and reviewed by our pharmacy team. How we use AI
Supplements and Herbs That Interact With Vancomycin
From the licensed clinical database we use, rolled up per supplement, most serious first.50 supplements and herbal products have documented interactions with Vancomycin in the licensed clinical database we use.
Most are manageable, but your pharmacist should know about everything you take, including vitamins and herbals.
- 3Major
- 36Moderate
- 11Minor
- ACTIVATED CHARCOALMajor
- ASARABACCAMajor
- SIBERIAN COCKLEBURMajor
- ARISTOLOCHIAModerate
- BACILLUS COAGULANSModerate
- Bacillus SubtilisModerate
- BIFIDOBACTERIUM ANIMALIS SUBSP. LACTISModerate
- BIFIDOBACTERIUM BIFIDUMModerate
Educational information from a licensed clinical database (Natural Medicines). See our data sources and update cadence. Not medical advice: an interaction being documented does not mean it will happen to you; do not start or stop medications or supplements without professional guidance.
Nutrients Vancomycin May Deplete
Nutrients Vancomycin has been linked with lower levels of, from the licensed clinical database we use.Vancomycin has been associated with lower levels of 7 nutrients in the clinical literature. This does not mean a deficiency will occur. It means these may be worth discussing with your pharmacist or healthcare provider, especially with long-term use.
Evidence and significance: 1 moderate, 6 lower / possible
- Vitamin K Moderate Depletion
- Biotin Insignificant Depletion
- Folic Acid Insignificant Depletion
- Riboflavin Insignificant Depletion
- Thiamine Insignificant Depletion
- Vitamin B12 Insignificant Depletion
- Vitamin B6 Insignificant Depletion
Educational information from a licensed clinical database (Natural Medicines), not medical advice. Do not start or stop medications or supplements without professional guidance.
Vancomycin: Pharmacist Answers to Common Questions
Quick, plain-English answers to the questions patients ask most about Vancomycin — the kind of thing our pharmacy team would talk through with you at the counter.
What is vancomycin used for?
Can I take vancomycin by mouth for any infection?
What side effects should I expect?
Why is IV vancomycin given so slowly?
Is vancomycin safe in pregnancy?
Does vancomycin affect the kidneys or hearing?
Is vancomycin available over the counter?
When was vancomycin first available?
Who makes vancomycin?
What is the brand name of vancomycin?
What is the generic name of Firvanq?
What drug class is vancomycin?
Is there a generic version of vancomycin?
What strengths does vancomycin come in?
How much does vancomycin cost?
Is there a vancomycin shortage?
Where can I read the vancomycin prescribing information (package insert)?
Is vancomycin gluten free?
Answers drafted from the FDA-approved label with AI and reviewed by our pharmacy team. How we use AI
Ask Anything About Vancomycin
Skip the scrolling. Ask in your own words and get an answer from Vancomycin’s FDA label and our pharmacists’ own work.
Name another drug or a supplement in your question and we check both.
AI answers from FDA labels and our own records, never the open internet. AI can make mistakes, so always check with your doctor or pharmacist.How this works
- Sources: Vancomycin’s FDA label, including the clinical studies it reports, and the label of any drug you name; our pharmacists’ own work, such as our Do Not Crush list and our published answers to readers’ questions; our pharmacy prices and the Natural Medicines supplement database.
- Written by AI: Answers are written by AI from those sources, and AI can make mistakes. Check what you read here with your doctor or pharmacist before you act on it.
- Reviewed afterward: Our pharmacy team reviews every question and answer afterward to check it for accuracy, and when we find an error, we correct how the box answers. Read more in How we use AI.
- Not medical advice. In an emergency, call 911, Poison Control at 1-800-222-1222, or 988.
More About Vancomycin on HelloPharmacist
Still have a question? A licensed pharmacist answers for free, as soon as they can.Vancomycin Forms and Strengths (How It Comes)
Vancomycin comes in 3 dose forms. Different forms and brands can have different approved uses, doses, schedules, and directions. Follow the instructions for your exact product, and do not switch forms without guidance from your prescriber or pharmacist.
Need a version that does not list lactose, a gluten source, a dye or gelatin? Inactive ingredients differ by manufacturer: see Vancomycin inactive ingredients by manufacturer.
Injection
How this form is used
- Tyzavan treats septicemia, infective endocarditis, skin and skin structure infections, bone infections and lower respiratory tract infections.
- Some vancomycin hydrochloride for injection products are also labeled for oral use in C. difficile-associated diarrhea and staphylococcal enterocolitis.
- Tyzavan is for IV use only and must not be taken by mouth.
- Tyzavan is infused slowly, over 60 minutes or longer, to reduce infusion reactions.
- Tyzavan should not be used in the first or second trimester of pregnancy.
Show 29 more strengths Show fewer strengths
Oral solution
How this form is used
- Vancomycin Hydrochloride for Oral Solution treats enterocolitis caused by Staphylococcus aureus and antibiotic-associated pseudomembranous colitis caused by C. difficile.
- Vancomycin Hydrochloride for Oral Solution is mixed with water before use.
- Vancomycin Hydrochloride for Oral Solution is generally taken in 3 or 4 divided doses a day for 7 to 10 days.
Capsule
How this form is used
- Vancocin capsules treat C. difficile-associated diarrhea.
- Vancocin capsules also treat enterocolitis caused by Staphylococcus aureus, including methicillin-resistant strains.
- Vancocin capsules must be taken by mouth for these infections, because IV vancomycin does not work for them.
- Vancocin capsules are generally taken in divided doses through the day for about 7 to 10 days.
Vancomycin on the U.S. Market: Products, Makers and Brands
How Vancomycin appears in the FDA’s National Drug Code Directory — including its dosage forms, strengths, brand names, manufacturers, and FDA-listed product records. These are directory records, not sales or prescription volume.
37 companies list 155 Vancomycin product records with the FDA, mostly as injection, oral solution, capsule; the earliest marketing or approval year on record is 1958. Brand names in the directory today include Firvanq, Vancocin and Tyzavan; the rest are generics.
FDA-listed product records by dose form (tablet variants merged) — FDA National Drug Code Directory. Record counts are not sales or prescription volume.
Also listed with the FDA, not a patient dose form: Powder (17) — bulk drug substance and unfinished product sold to compounders and other manufacturers to finish, and multi-item kits. These aren’t counted in the dose-form total above.
Share of FDA-listed product records by manufacturer — FDA National Drug Code Directory. Record counts are not sales or prescription volume.
How Widely Vancomycin Is Used (Medicaid Data)
How many Vancomycin prescriptions Medicaid paid for in Q1–Q4 2025, every brand, strength and form together. Medicaid is one program, so total U.S. use is higher.
How commonly is Vancomycin prescribed? Of the 1,682 medications we measure, Vancomycin ranks #446 by Medicaid prescriptions — more than 73% of them.
Utilization by Vancomycin product
Pick a strength and form to see its own numbers. Brand and generic versions are counted together.
vancomycin 1000 MG Injection Most dispensed
13 of 55 listed NDCs had Medicaid claims. RxNorm 1807513
vancomycin 125 MG Oral Capsule
8 of 30 listed NDCs had Medicaid claims. RxNorm 313570
vancomycin 100 MG/ML Injectable Solution
10 of 22 listed NDCs had Medicaid claims. RxNorm 239209
200 ML vancomycin 5 MG/ML Injection
3 of 8 listed NDCs had Medicaid claims. RxNorm 1807508
vancomycin 50 MG/ML Injectable Solution
8 of 18 listed NDCs had Medicaid claims. RxNorm 313572
vancomycin 500 MG Injection
8 of 52 listed NDCs had Medicaid claims. RxNorm 1807516
250 ML vancomycin 5 MG/ML Injection
2 of 5 listed NDCs had Medicaid claims. RxNorm 2387078
300 ML vancomycin 5 MG/ML Injection
2 of 5 listed NDCs had Medicaid claims. RxNorm 2118448
vancomycin 250 MG Oral Capsule
4 of 31 listed NDCs had Medicaid claims. RxNorm 313571
vancomycin 50 MG/ML Oral Solution
8 of 23 listed NDCs had Medicaid claims. RxNorm 2000134
150 ML vancomycin 5 MG/ML Injection
3 of 8 listed NDCs had Medicaid claims. RxNorm 1807510
vancomycin 750 MG Injection
6 of 22 listed NDCs had Medicaid claims. RxNorm 1807518
vancomycin 1250 MG Injection
5 of 16 listed NDCs had Medicaid claims. RxNorm 2049888
vancomycin 1500 MG Injection
4 of 18 listed NDCs had Medicaid claims. RxNorm 2049890
100 ML vancomycin 5 MG/ML Injection
3 of 8 listed NDCs had Medicaid claims. RxNorm 1807511
vancomycin 25 MG/ML Oral Solution
6 of 7 listed NDCs had Medicaid claims. RxNorm 2000127
350 ML vancomycin 5 MG/ML Injection
1 of 4 listed NDCs had Medicaid claims. RxNorm 2387079
400 ML vancomycin 5 MG/ML Injection
1 of 4 listed NDCs had Medicaid claims. RxNorm 2118449
vancomycin 1750 MG Injection
1 of 2 listed NDCs had Medicaid claims. RxNorm 2688632
vancomycin 2000 MG Injection
1 of 2 listed NDCs had Medicaid claims. RxNorm 2688634
Dollars are what Medicaid paid before the rebates drug makers send back, so its real cost is lower.
Source: Medicaid State Drug Utilization Data (CMS), all states. 97 of the 340 listed Vancomycin NDCs had Medicaid claims.
Compare Vancomycin Products
A representative set of FDA-listed product records for Vancomycin — across manufacturers, strengths, and dosage forms, grouped by form with each product’s manufacturer and how the FDA approved it. The same medicine may be made and packaged by different companies, so a single drug can have many directory entries. (It’s also why a refill can look different — a new shape, color, or box — even though it contains the same medication.)
| Strength | Route | Manufacturer / Labeler | Category ⓘ | Details |
|---|---|---|---|---|
| 💊Capsule | ||||
| 250 mg | Oral | Advanced Rx of Tennessee, LLC | NDA AUTHORIZED GENERIC | View NDC → |
| 125 mg | Oral | ANI Pharmaceuticals, Inc. | NDA AUTHORIZED GENERIC | View NDC → |
| 125 mg | Oral | ANI Pharmaceuticals, Inc. | NDA | View NDC → |
| 250 mg | Oral | ANI Pharmaceuticals, Inc. | NDA AUTHORIZED GENERIC | View NDC → |
| 250 mg | Oral | ANI Pharmaceuticals, Inc. | NDA | View NDC → |
| 125 mg | Oral | Bryant Ranch Prepack | ANDA | View NDC → |
| 250 mg | Oral | Bryant Ranch Prepack | ANDA | View NDC → |
| 125 mg | Oral | Cameron Pharmaceuticals | ANDA | View NDC → |
| 250 mg | Oral | Cameron Pharmaceuticals | ANDA | View NDC → |
| 125 mg | Oral | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. × 2 listings | ANDA | View NDC → |
| 250 mg | Oral | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. × 2 listings | ANDA | View NDC → |
| 125 mg | Oral | PAI Holdings, LLC dba PAI Pharma | ANDA | View NDC → |
| 250 mg | Oral | PAI Holdings, LLC dba PAI Pharma | ANDA | View NDC → |
| 125 mg | Oral | Redpharm Drug | ANDA | View NDC → |
| 125 mg | Oral | Redpharm Drug | NDA AUTHORIZED GENERIC | View NDC → |
| 125 mg | Oral | Strides Pharma Science Limited | ANDA | View NDC → |
| 250 mg | Oral | Strides Pharma Science Limited | ANDA | View NDC → |
| 💊Injection | ||||
| 750 mg | Intravenous, Oral | Avenacy, LLC | NDA | View NDC → |
| 1.25 g | Intravenous, Oral | Avenacy, LLC | NDA | View NDC → |
| 1.5 g | Intravenous, Oral | Avenacy, LLC | NDA | View NDC → |
| 500 mg/100 mL | Intravenous | Baxter Healthcare Corporation × 2 listings | NDA | View NDC → |
| 750 mg/150 mL | Intravenous | Baxter Healthcare Corporation × 2 listings | NDA | View NDC → |
| 1 g/200 mL | Intravenous | Baxter Healthcare Corporation × 2 listings | NDA | View NDC → |
| 1.25 g/250 mL | Intravitreal | Baxter Healthcare Corporation | NDA | View NDC → |
| 1.5 g/300 mL | Intravitreal | Baxter Healthcare Corporation | NDA | View NDC → |
| 5 g | Intravenous | BluePoint Laboratories | ANDA | View NDC → |
| 10 g | Intravenous | BluePoint Laboratories | ANDA | View NDC → |
| 500 mg/10 mL | Intravenous | Camber Pharmaceuticals, Inc. | ANDA | View NDC → |
| 1 g/20 mL | Intravenous | Camber Pharmaceuticals, Inc. | ANDA | View NDC → |
| 500 mg/5 mL | Intravenous | Civica, Inc | ANDA | View NDC → |
| 500 mg/10 mL | Intravenous | Civica, Inc | ANDA | View NDC → |
| 1 g | Intravenous | Civica, Inc | ANDA | View NDC → |
| 500 mg/10 mL | Intravenous | Eugia US LLC | ANDA | View NDC → |
| 1 g/20 mL | Intravenous | Eugia US LLC | ANDA | View NDC → |
| 1.25 g/25 mL | Intravenous | Eugia US LLC | ANDA | View NDC → |
| 1.5 g/30 mL | Intravenous | Eugia US LLC | ANDA | View NDC → |
| 5 g | Intravenous | Eugia US LLC | ANDA | View NDC → |
| 10 g | Intravenous | Eugia US LLC | ANDA | View NDC → |
| 500 mg/10 mL | Intravenous | Eurofarma, Inc. | ANDA | View NDC → |
| 1 g/20 mL | Intravenous | Eurofarma, Inc. | ANDA | View NDC → |
| 500 mg/10 mL | Intravenous | Fresenius Kabi USA, LLC | ANDA | View NDC → |
| 750 mg/15 mL | Intravenous | Fresenius Kabi USA, LLC | ANDA | View NDC → |
| 1 g/20 mL | Intravenous | Fresenius Kabi USA, LLC | ANDA | View NDC → |
| 5 g/100 mL | Intravenous | Fresenius Kabi USA, LLC | ANDA | View NDC → |
| 10 g/100 mL | Intravenous | Fresenius Kabi USA, LLC | ANDA | View NDC → |
| 500 mg/10 mL | Intravenous | Gland Pharma Limited | ANDA | View NDC → |
| 750 mg | Intravenous | Gland Pharma Limited | ANDA | View NDC → |
| 1 g/20 mL | Intravenous | Gland Pharma Limited | ANDA | View NDC → |
| 1.25 g | Intravenous | Gland Pharma Limited | ANDA | View NDC → |
| 1.5 g | Intravenous | Gland Pharma Limited | ANDA | View NDC → |
| 5 g/100 mL | Intravenous | Gland Pharma Limited | ANDA | View NDC → |
| 10 g/100 mL | Intravenous | Gland Pharma Limited | ANDA | View NDC → |
| 500 mg/10 mL | Intravenous | Glenmark Pharmaceuticals Inc., Usa | ANDA | View NDC → |
| 750 mg | Intravenous | Glenmark Pharmaceuticals Inc., Usa | ANDA | View NDC → |
| 1 g/20 mL | Intravenous | Glenmark Pharmaceuticals Inc., Usa | ANDA | View NDC → |
| 1.25 g | Intravenous | Glenmark Pharmaceuticals Inc., Usa | ANDA | View NDC → |
| 1.5 g | Intravenous | Glenmark Pharmaceuticals Inc., Usa | ANDA | View NDC → |
| 5 g/100 mL | Intravenous | Glenmark Pharmaceuticals Inc., Usa | ANDA | View NDC → |
| 10 g/100 mL | Intravenous | Glenmark Pharmaceuticals Inc., Usa | ANDA | View NDC → |
| 500 mg | Intravenous | Henry Schein, Inc. | ANDA | View NDC → |
| 500 mg | Intravenous | Hikma Pharmaceuticals USA Inc. | ANDA | View NDC → |
| 500 mg/100 mL | Intravenous | Hikma Pharmaceuticals USA Inc. | NDA | View NDC → |
| 513 mg/mg | Intravenous, Oral | Hikma Pharmaceuticals Usa Inc. | NDA | View NDC → |
| 750 mg | Intravenous | Hikma Pharmaceuticals USA Inc. | ANDA | View NDC → |
| 750 mg/150 mL | Intravenous | Hikma Pharmaceuticals USA Inc. | NDA | View NDC → |
| 769 mg/mg | Intravenous, Oral | Hikma Pharmaceuticals Usa Inc. | NDA | View NDC → |
| 1 g | Intravenous | Hikma Pharmaceuticals USA Inc. | ANDA | View NDC → |
| 1 g/200 mL | Intravenous | Hikma Pharmaceuticals USA Inc. | NDA | View NDC → |
| 1025 mg/mg | Intravenous, Oral | Hikma Pharmaceuticals Usa Inc. | NDA | View NDC → |
| 1.25 g | Intravenous | Hikma Pharmaceuticals USA Inc. | ANDA | View NDC → |
| 1.25 g/250 mL | Intravenous | Hikma Pharmaceuticals USA Inc. | NDA | View NDC → |
| 1280 mg/mg | Intravenous, Oral | Hikma Pharmaceuticals Usa Inc. | NDA | View NDC → |
| 1.5 g | Intravenous | Hikma Pharmaceuticals USA Inc. | ANDA | View NDC → |
| 1.5 g/300 mL | Intravenous | Hikma Pharmaceuticals USA Inc. | NDA | View NDC → |
| 1540 mg/mg | Intravenous, Oral | Hikma Pharmaceuticals Usa Inc. | NDA | View NDC → |
| 1.75 g/350 mL | Intravenous | Hikma Pharmaceuticals USA Inc. | NDA | View NDC → |
| 2 g/400 mL | Intravenous | Hikma Pharmaceuticals USA Inc. | NDA | View NDC → |
| 5 g | Intravenous | Hikma Pharmaceuticals USA Inc. | ANDA | View NDC → |
| 5.13 g/g | Intravenous, Oral | Hikma Pharmaceuticals Usa Inc. | NDA | View NDC → |
| 10 g | Intravenous | Hikma Pharmaceuticals USA Inc. | ANDA | View NDC → |
| 10.25 g/g | Intravenous, Oral | Hikma Pharmaceuticals Usa Inc. | NDA | View NDC → |
| 500 mg | Intravenous | Hospira, Inc. | ANDA | View NDC → |
| 500 mg/5 mL | Intravenous | Hospira, Inc. | ANDA | View NDC → |
| 500 mg/10 mL | Intravenous | Hospira, Inc. | ANDA | View NDC → |
| 750 mg | Intravenous | Hospira, Inc. | ANDA | View NDC → |
| 1 g | Intravenous | Hospira, Inc. | ANDA | View NDC → |
| 1.5 g | Intravenous | Hospira, Inc. | ANDA | View NDC → |
| 500 mg/10 mL | Intravenous | Meitheal Pharmaceuticals Inc. | ANDA | View NDC → |
| 750 mg/15 mL | Intravenous | Meitheal Pharmaceuticals Inc. | ANDA | View NDC → |
| 1 g/20 mL | Intravenous | Meitheal Pharmaceuticals Inc. | ANDA | View NDC → |
| 5 g/100 mL | Intravenous | Meitheal Pharmaceuticals Inc. | ANDA | View NDC → |
| 10 g/95 mL | Intravenous | Meitheal Pharmaceuticals Inc. | ANDA | View NDC → |
| 500 mg/10 mL | Intravenous | Mylan Institutional LLC | ANDA | View NDC → |
| 750 mg/15 mL | Intravenous | Mylan Institutional LLC | NDA | View NDC → |
| 1 g/20 mL | Intravenous | Mylan Institutional LLC | ANDA | View NDC → |
| 1.25 g/25 mL | Intravenous | Mylan Institutional LLC | NDA | View NDC → |
| 1.5 g/30 mL | Intravenous | Mylan Institutional LLC | NDA | View NDC → |
| 1.75 g/35 mL | Intravenous | Mylan Institutional LLC | NDA | View NDC → |
| 2 g/40 mL | Intravenous | Mylan Institutional LLC | NDA | View NDC → |
| 5 g/100 mL | Intravenous | Mylan Institutional LLC | ANDA | View NDC → |
| 10 g/100 mL | Intravenous | Mylan Institutional LLC | ANDA | View NDC → |
| 1 g/20 mL | Intravenous | Plano Pharmaceuticals Inc. | ANDA | View NDC → |
| 5 g/100 mL | Intravenous | Plano Pharmaceuticals Inc. | ANDA | View NDC → |
| 500 mg/10 mL | Intravenous | Sagent Pharmaceuticals | ANDA | View NDC → |
| 750 mg/15 mL | Intravenous | Sagent Pharmaceuticals | ANDA | View NDC → |
| 1 g/20 mL | Intravenous | Sagent Pharmaceuticals | ANDA | View NDC → |
| 1.25 g/25 mL | Intravenous | Sagent Pharmaceuticals | ANDA | View NDC → |
| 1.5 g/30 mL | Intravenous | Sagent Pharmaceuticals | ANDA | View NDC → |
| 5 g/100 mL | Intravenous | Sagent Pharmaceuticals | ANDA | View NDC → |
| 10 g/100 mL | Intravenous | Sagent Pharmaceuticals | ANDA | View NDC → |
| 100 g | Intravenous | Samson Medical Technologies Llc | ANDA | View NDC → |
| 500 mg | Intravenous | Slate Run Pharmaceuticals, LLC | ANDA | View NDC → |
| 1 g | Intravenous | Slate Run Pharmaceuticals, LLC | ANDA | View NDC → |
| 5 g | Intravenous | Slate Run Pharmaceuticals, LLC | ANDA | View NDC → |
| 10 g | Intravenous | Slate Run Pharmaceuticals, LLC | ANDA | View NDC → |
| 750 mg/20 mL | Intravenous | Steriscience Specialties Private Limited | ANDA | View NDC → |
| 1.25 g/30 mL | Intravenous | Steriscience Specialties Private Limited | ANDA | View NDC → |
| 1.5 g/30 mL | Intravenous | Steriscience Specialties Private Limited | ANDA | View NDC → |
| 500 mg | Intravenous | Xellia Pharmaceuticals USA LLC | ANDA | View NDC → |
| 500 mg/100 mL | Intravenous | Xellia Pharmaceuticals USA LLC | NDA | View NDC → |
| 750 mg/150 mL | Intravenous | Xellia Pharmaceuticals USA LLC | NDA | View NDC → |
| 1 g | Intravenous | Xellia Pharmaceuticals USA LLC | ANDA | View NDC → |
| 1 g/200 mL | Intravenous | Xellia Pharmaceuticals USA LLC | NDA | View NDC → |
| 1.25 g/250 mL | Intravenous | Xellia Pharmaceuticals USA LLC | NDA | View NDC → |
| 1.5 g/300 mL | Intravenous | Xellia Pharmaceuticals USA LLC | NDA | View NDC → |
| 1.75 g/350 mL | Intravenous | Xellia Pharmaceuticals USA LLC | NDA | View NDC → |
| 2 g/400 mL | Intravenous | Xellia Pharmaceuticals USA LLC | NDA | View NDC → |
| 1.25 g | Intravenous | XGen Pharmaceuticals DJB, Inc. | ANDA | View NDC → |
| 1.5 g | Intravenous | XGen Pharmaceuticals DJB, Inc. | ANDA | View NDC → |
| 10.25 g/g | Intravenous, Oral | Zhejiang Novus Pharma Co., Ltd. | NDA | View NDC → |
| 💊Oral solution | ||||
| 250 mg/5 mL | Oral | Amneal Pharmaceuticals NY LLC | ANDA | View NDC → |
| 250 mg/5 mL | Oral | ANI Pharmaceuticals, Inc. | ANDA | View NDC → |
| 250 mg/5 mL | Oral | Bryant Ranch Prepack × 6 listings | ANDA | View NDC → |
| 💊Kits | ||||
| — | — | Ascend Laboratories, LLC × 2 listings | ANDA | View NDC → |
| — | — | Aurobindo Pharma Limited × 2 listings | ANDA | View NDC → |
| — | — | Azurity Pharmaceuticals, Inc × 4 listings | NDA | View NDC → |
| — | — | Wilshire Pharmaceuticals, Inc. × 4 listings | NDA AUTHORIZED GENERIC | View NDC → |
Showing 155 of 155 products — FDA National Drug Code Directory. See every product, package size and price: browse all 155 Vancomycin NDCs →
Vancomycin Side Effects Reported to the FDA (FAERS)
After a medicine reaches the market, patients, doctors and drugmakers can send the FDA reports of problems they think may be linked to it. Here’s what’s been reported for Vancomycin — a signal of what to watch for, not proof the drug caused it.
Source: openFDA, from the FDA Adverse Event Reporting System (FAERS). These are voluntary reports — they don’t prove the drug caused the effect, and counts reflect how often something was reported, not how often it actually happens. Reports also often name the very problem the medicine is taken for — a common reason to file one is that the drug didn’t help — so for a pain reliever you may see “pain” high on the list; that points to why the report was filed, not to the drug causing the symptom. This counts every report that lists Vancomycin in any role, so the total runs higher than the FDA’s official dashboard, which counts only cases where the drug is the suspect. For the authoritative figures, see the FDA FAERS Public Dashboard. Always talk to your pharmacist or doctor.
Vancomycin FDA Approval History
How Vancomycin went from FDA review to the pharmacy shelf — the key milestones in its regulatory journey.
Source: Drugs@FDA.
Vancomycin Recall History
A recall is when a specific batch of a medicine is pulled from the market — usually a manufacturing issue, not a problem with the drug itself. Class I is most serious, Class III least.
The FDA’s enforcement reports list 4 Vancomycin recalls since July 2021, covering 5 product listings. One of them is still ongoing and is listed first. A recall names specific lots from one company, so check the lot number on your own bottle rather than assuming every product is affected; your pharmacist can check whether your supply came from an affected lot.
- Vancomycin Injection, USP, in 0.9% Sodium Chloride, 1g per 200 mL (5 mg/mL) in GALAXY Single-Dose Container, Rx only, Sterile Nonpyrogenic, Baxter Healthcare Corporation, Deerfield, IL, 60015 USA, ND… Lots: Lot # NC193894, Exp Date: 04/25/2027. FDA record D-0820-2026 →
- Vancomycin Injection, USP in 5% Dextrose, 1 g per 200mL (5 mg/mL), in GALAXY Single-Dose Container, Rx only, Sterile Nonpyrogenic, Iso-osmotic, Baxter Healthcare Corporation, Deerfield, IL, 60015 USA… Lots: Lot # NC188678, Exp Date: 12/1/2026; Lot # NC188814, Exp Date: 12/5/2026; Lot # NC188944, Exp Date: 12/8/2026; Lot # NC193610, Exp Date: 4/21/2027, Lot # NC193665, Exp Date: 4/23/2027. FDA record D-0805-2026 →
- Vancomycin Hydrochloride for Oral Solution, USP, 250 mg per 5 mL, packaged as (a) 80 mL bottle, NDC 69238-2261-3; (b) 150 mL bottle, NDC 69238-2261-7; (c)300 mL bottle, NDC 69238-2261-5; Rx only, Dis… Lots: Lot # (a) 22613003A, Exp. date 09/30/2025; (b) 22613004A, 22613005A, Exp. date 09/30/2025; (c) 22613005B, Exp. date 09/30/2025 FDA record D-0442-2024 →
- Vancomycin Hydrochloride for Injection, USP, 1.5 g/vial, Sterile powder, Single-dose Fliptop Vial, 10 vials per carton, Rx only, Distributed by: Hospira, Inc., Lake Forest, IL 60045. NDC Vial 0409-35… Lots: Lot: 33045BA, EXP 1SEP2023 FDA record D-0184-2023 →
- Firvanq (vancomycin hydrochloride for oral solution), Vancomycin 50 mg/mL Kit, Each Kit Includes: 1 bottle containing 7.7 g Vancomycin Hydrochloride USP, powder for oral solution and 1 bottle contain… Lots: Lot # 21035, Exp 7/31/2022 FDA record D-0003-2022 →
Source: FDA enforcement (recall) reports, via openFDA; our copy was last updated Nov 19, 2026.
Vancomycin in RxNorm: From Ingredient to Every Form and Strength
RxNorm is the U.S. National Library of Medicine’s standard name for every version of a medicine, the code pharmacy and prescribing systems share. This page starts from one ingredient (IN); each dose form (SCDF) branches from it, and each exact strength (SCD) from its form. Combination products are separate concepts with their own pages.
- Dose forms
- 4
- Strengths
- 21
- Forms in current FDA listings
- 4 of 4
RxCUI 11124 -
Dose form (SCDF) InjectionIn current FDA listings
RxCUI 1807507Its 15 strengths (SCD)-
100 mL vancomycin 5 mg/mL
RxCUI 1807511 -
150 mL vancomycin 5 mg/mL
RxCUI 1807510 -
200 mL vancomycin 5 mg/mL
RxCUI 1807508 -
250 mg
RxCUI 2049891 -
250 mL vancomycin 5 mg/mL
RxCUI 2387078 -
300 mL vancomycin 5 mg/mL
RxCUI 2118448 -
350 mL vancomycin 5 mg/mL
RxCUI 2387079 -
400 mL vancomycin 5 mg/mL
RxCUI 2118449 -
500 mg
RxCUI 1807516 -
750 mg
RxCUI 1807518 -
1000 mg
RxCUI 1807513 -
1250 mg
RxCUI 2049888 -
1500 mg
RxCUI 2049890 -
1750 mg
RxCUI 2688632 -
2000 mg
RxCUI 2688634
-
100 mL vancomycin 5 mg/mL
RxNorm is the U.S. National Library of Medicine’s normalized drug vocabulary. Its concept hierarchy can include forms that are not currently marketed; the status on each branch compares that concept with current FDA listings. RxCUIs identify vocabulary concepts, not individual packages or manufacturers.
Vancomycin Supply and Shortage Status
Whether Vancomycin is in short supply in the U.S. right now, plus any shortage history the FDA has on record. A shortage usually reflects a manufacturing or demand issue — not a safety problem with the drug.
Source: openFDA, from the FDA Drug Shortages database.
What Vancomycin Costs Pharmacies (NADAC Benchmark)
What pharmacies pay to buy Vancomycin: the national average from CMS’s weekly NADAC survey, as of Nov 18, 2026. It is the pharmacy’s cost, not your price at the counter.
How the Pharmacy Price Has Changed
Pick a form and a strength to see how its price has changed since Nov 2023.
For the generic 500 mg injection, pharmacies paid an average of $2.31 each as of Nov 18, 2026, the same as a year earlier.
- What pharmacies pay now
- $2.31
- each, as of Nov 18, 2026
- Last 4 weeks
- No change
- from $2.31 on Oct 21, 2026
- Last 12 months
- No change
- from $2.31 on Nov 19, 2025
- Lowest and highest since Jun 2024
- $2.16 to $2.63
- each
See the numbers, month by month
| Month | Pharmacy price |
|---|---|
| Nov 2026 | $2.31 |
| Oct 2026 | $2.31 |
| Sep 2026 | $2.31 |
| Aug 2026 | $2.31 |
| Jul 2026 | $2.31 |
| Jun 2026 | $2.31 |
| May 2026 | $2.31 |
| Apr 2026 | $2.31 |
| Mar 2026 | $2.31 |
| Feb 2026 | $2.31 |
| Jan 2026 | $2.31 |
| Dec 2025 | $2.31 |
| Nov 2025 | $2.31 |
| Oct 2025 | $2.31 |
| Sep 2025 | $2.35 |
| Aug 2025 | $2.35 |
| Jul 2025 | $2.35 |
| Jun 2025 | $2.35 |
| May 2025 | $2.35 |
| Apr 2025 | $2.35 |
| Mar 2025 | $2.35 |
| Feb 2025 | $2.35 |
| Jan 2025 | $2.45 |
| Dec 2024 | $2.48 |
| Nov 2024 | $2.63 |
| Oct 2024 | $2.44 |
| Sep 2024 | $2.16 |
| Aug 2024 | $2.43 |
| Jul 2024 | $2.23 |
| Jun 2024 | $2.23 |
| Form | Strength | Version | What pharmacies pay | |
|---|---|---|---|---|
| Injection · Intravenous | 500 mg | Generic | $2.31 each | NDC details & price history |
| Injection · Intravenous | 500 mg/10 mL | Generic | $2.31 each | NDC details & price history |
| Capsule · Oral | 125 mg | Generic | $1.11 per capsule | NDC details & price history |
| Capsule · Oral | 250 mg | Generic | $2.01 per capsule | NDC details & price history |
| Oral solution · Oral | 25 mg/mL | Generic | $0.402–$0.693 per mL | NDC details & price history |
| Oral solution · Oral | 250 mg/5 mL | Generic | $0.566–$2.91 per mL | NDC details & price history |
Source: CMS National Average Drug Acquisition Cost (NADAC). Each row spans the package sizes CMS priced; the generic and the brand are priced separately.
Vancomycin Brand Names
Vancomycin has 3 brand names on record: Firvanq, Vancocin and Tyzavan. A brand name is one company's name for the medicine; a generic has the same active ingredient under its generic name.
Who Makes Vancomycin: Manufacturers and Labelers
37 companies list Vancomycin products with the FDA. By number of product records, the largest are Hikma Pharmaceuticals USA Inc., Mylan Institutional LLC, Xellia Pharmaceuticals USA LLC. Labelers include manufacturers and repackagers; the product in your bottle depends on which one your pharmacy stocks.
…and 13 more on the FDA NDC directory.
Sources for This Vancomycin Page
Core label, product, RxNorm, safety, and utilization data on this page come from the sources identified below. AI-written, editorial, and licensed sections are labeled separately.
How this page is built
HelloPharmacist combines public FDA and NLM records and does not author the underlying clinical facts. The plain-language sections are written with AI from the FDA-approved label text and reviewed by our pharmacy team before publication. Hikma Pharmaceuticals USA Inc. is the representative DailyMed label linked for verification and dates. This is general education, not medical advice: always talk to your doctor or pharmacist about your own medicines. How we build and review drug pages →